News

INFANT Researchers contributing to The Biophotonics Congress: Biomedical Optics

By |2022-04-27T11:14:41+01:00April 27th, 2022|

📣 The Biophotonics Congress: Biomedical Optics is one of the leading events that gathers international researchers engaged in optical methods to advance application of medical science to clinical practice. 🗣 27th April - Clinical research fellow Jurate Panaviene at INFANT is going to present the results of the Pilot trial investigating non-invasive, optical technology-based lung [...]

INFANT Researchers presenting at the WOA & BSACI 2022 Meeting

By |2022-04-27T10:25:22+01:00April 27th, 2022|

📣INFANT is at the World Allergy Organization & BSACI 2022 UK Conference 📅25th-27th April 2022, Edinburgh International Conference Centre (EICC) The joint conference is a fantastic opportunity for BSACI members to learn from colleagues from around the world as they present current practice, important clinical challenges and recent advances in allergy diagnostics and management in [...]

INFANT Researchers Contribution to PAS 2022 Meeting

By |2022-04-20T12:04:25+01:00April 20th, 2022|

INFANT is delighted to be involved in the PAS 2022 Meeting in Denver 21-25 April. Members of the INFANT team will join thousands of physicians, researchers, and Allied health professionals from 60 + specialty areas as they come together to share research, explore new collaboratives, and experience the best the paediatric research community has to [...]

Dr Juan Trujillo’s Research Into Strategies That Help CMPA Patients Reintroduce Milk Into Their Diet

By |2022-04-05T15:03:14+01:00April 5th, 2022|

With the support of the National Dairy Council and Dairy Research Ireland, INFANT’s Dr Juan Trujillo, Senior Lecturer in UCC and Consultant paediatric allergist at Cork University Hospital, is the lead investigator on the COWS project, a study that aims to compare three different strategies that will help milk protein allergy (CMPA) patients reintroduce milk into [...]

PhD Profile: Tamara Escañuela Sánchez’s Study to Raise Awareness of and Reduce the Risk Factors Connected with Stillbirth

By |2022-03-30T15:09:53+01:00March 30th, 2022|

A graduate of the Universitat Autònoma de Barcelona, INFANT PhD candidate, Tamara Escañuela Sánchez came to University College Cork to study under Professor Keelin O’Donoghue and develop a behaviour change intervention model that will raise awareness of and reduce the risk factors associated with stillbirth in Ireland. Tamara’s multidisciplinary supervisory team is composed by Dr. [...]

Liltoda wins UCC Innovation Award for CogniTOT Application

By |2022-03-24T14:58:48+00:00March 24th, 2022|

Liltoda Ltd, the first academic spin out to emanate from the INFANT Research Centre at University College Cork, has been awarded a GatewayUCC Sprint Award by Professor John O’Halloran, President of UCC. Launched in August 2021, Liltoda aims to develop and market novel technology-based solutions to the cognitive assessment of young children. Its first product, [...]

Soraia Ventura Presents Her Research at World Sleep Congress

By |2022-03-23T11:28:24+00:00March 23rd, 2022|

INFANT PhD researcher, Soraia Ventura, presented her research at the World Sleep Congress in Rome on March 14 and 15. The Congress consistently gathers the best minds in sleep medicine and research for multiple days of scientific sessions and networking. A truly global meeting, 77 countries were represented at World Sleep 2019, the last in-person [...]

INFANT Seminar Series: Dr Mark O’Sullivan to Discuss Neonatal EEG Monitoring – Hardware, AI and Medical Device Design

By |2022-03-22T10:34:57+00:00March 22nd, 2022|

Our next INFANT seminar will be this Friday, March 25th at 12pm, when Dr Mark O'Sullivan will present "Neonatal EEG monitoring - hardware, AI and medical device design". Dr O'Sullivan will present updates on the Neurobell Project, which aims to develop a portable neonatal EEG monitor with seizure detection, including methodologies for medical device design [...]

INFANT Seminar Series: Dr Dhanis Lad to Discuss the STOP AD Randomised Controlled Trial

By |2022-03-09T14:31:21+00:00March 9th, 2022|

Presentation title: Early initiation of short-term emollient use for the prevention of atopic dermatitis in high-risk infants – the STOP AD randomised controlled trial Atopic dermatitis (AD), also known as eczema, is a chronic inflammatory skin condition, characterized by dry, red and itchy skin. AD usually begins in infancy and affects up to one fifth of [...]